Clinicopathological features and prognostic analysis of 247 small cell lung cancer with limited-stage after surgery
Open Access
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 108, 84-92
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China
This publication has 30 references indexed in Scilit:
- Progress in the management of limited‐stage small cell lung cancerCancer, 2013
- Survival of patients with small cell lung cancer undergoing lung resection in England, 1998–2009Thorax, 2013
- Retrospective study of surgical resection in the treatment of limited stage small cell lung cancerThoracic Cancer, 2013
- Variation of Tumor-Infiltrating Lymphocytes in Human Cancers: Controversy on Clinical SignificanceImmunotherapy, 2011
- Factors associated with recurrence in patients with curatively resected stage I–II lung cancerLung Cancer, 2011
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary AdenocarcinomaNew England Journal of Medicine, 2009
- The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant TumoursJournal of Thoracic Oncology, 2007
- Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has comeThe Journal of Thoracic and Cardiovascular Surgery, 2005
- Small Cell Lung Carcinoma (SCLC)American Journal of Surgical Pathology, 2002
- Histological typing of lung and pleural tumours: third editionJournal of Clinical Pathology, 2001